P a g e g |g1
SOCRA CERTIFICATION 2025 ACTUAL EXAM Q
g g g g g
UESTIONS WITH 100% CORRECT SOLUTIONS
g g g g
| GUARANTEED SUCCESS.
g g
Usegofgplacebog-gcorrectganswerg-
gThegbenefits,grisks,geffectivess,getc.gmustgbegtestedgexcept:gWhengnogprov
engintervetiongexists.gThengthegusegofgplacebo,gorgnogintervetiongisgaccepta
ble.gAlso,gifgagcompellinggandgscientificgmethodologicalgreasonsgforginterven
tion
PublicgDiscolsuregwithgINDsg-gcorrectganswerg-
g1.gINDgwillgnotgbegdisclosedgunlessgpreviouslygdone.
2.gFDAgwillgdisclosegupongrequestgtogangindividualggivengangINDghasgbeengg
ivengcopygofgreportgonghowgitgrelatesgtoguse.
ReportinggTimegFramesg-gcorrectganswerg-
g1.gFatalgorgLifegthreateninggunexpectedgADRsg-
gQualifygforgrapidgreportingg-gASAPg-gnoglatergthang7gdaysg-
gfollowgupgreportgnoglatergthang8gadditionalgdays.
2.gAllgothergserious,gunexpectedgADRsgmustgbegfiledgasapg-
gbutgnoglatergthang15gcalendargdays.
IRBgwillgdeterminegifgstudygisgmorallygjustifiedgandgdemonstratesgwhatg4gkey
gitems?g-gcorrectganswerg-g1.gAdequategDesign.
2. FavorablegRisk/Benefitgratio.
3. Equablegselectiongofgsubjects.
4. ICFgofgsubjects.
, P a g e g |g2
AdversegEventg(Definition)g-gcorrectganswerg-
gAnyguntowardgmedicalgoccurrencegassociatedgwithgthegusegofgagdrugginghu
mansgwhethergorgnotgconsideredgdruggrelated.gItgcangthereforegbeganygunfa
vorablegandgunintendedgsign,gsymptom,gorgdiagnosisgassociatedgwithgthegu
segofgagmedicinalginvestigationalgproductgwhethergorgnotgrelated.
Explaingthegrulesgrelatinggtogfinancialgdisclosure?g-gcorrectganswerg-
gResponsiblegforginmplementinggthegpublicgandgconfidentialgfinancialgdisclu
sregsystemsgtogpreventgconflictsgofginterestgandgtogidentifygpotentialgconflicts
gbygprovidinggreviewgofgthegfinancialginterestgingbothgcurrentgandgprospectiv
egemployees.
Whatgisgminimalgrisk.g-gcorrectganswerg-
gThegprobabilitygandgmagnitudegofgharmgorgdiscomfortganticipatedgingthegres
earchgaregnotggreatergingandgofgthemselvesgthangthosegordinarilygencounter
edgingdailyglife.
AssentgforgChildreng-gcorrectganswerg-
g1.gPermissiongofgeachgchild'sgparentsgmustgbeggranted.gMightgbegonegorgbot
h.gMustgbegdocumented.
2. Assentgshouldgbegobtainedgunless.gCapacitygofgchildgisglimitedgsogthey
gcan'tgunderstand.gInterventiongofgtrialgisgbeneficialgandgonlygavailablegth
roughgtrial.
3. OrgifgIRBgfeels:gNogmoregthangminimalgrisk.gWaivergwillgnotgaffectgsubject
grights.gResearchgcouldn'tghappengwithoutgassent.gAdditionalginfogprovided
gasgneeded.
, P a g e g |g3
WhatgciricalgquestiongmustgbegansweredgbygthegIRB?g-gcorrectganswerg-
gDoesgthegsumgofgbenefitsgandgimportancegofgknowledgeggainedgfromgrese
archgoutweighgrisksgtogpartipants?
WhengisgitgokgtogtestgagnewginterventiongagainstgagPlacebogandgnotgagainstg
bestgprovengintervention?g(DeclarationgofgHelsinki)g-gcorrectganswerg-g1.
Whengnogprovenginterventiongexists.
2. Soundgmethodicalgreasonsgrequiresgitgtogdeterminegefficacygorgsafetygof
gangintervention.
3. Subjectsgthatgreceivegplacebogwillgnotgbegsubjectgtogadditionalgrisksgduegto
gnotgreceivinggbestgoption
HowglonggaregIRBgregistrationsgeffective?g-gcorrectganswerg-g3gyears
AdministrativegActionsgforgNon-CompliancegforgIRBsg-gcorrectganswerg-
gIfgFDAgobservesgnon-compliancegduringginspection:gMay
1. withholdgapprovalgofgnewgstudies.
2. Nognewgsubjectsgbegaddedgtogongoinggstudies.
3. Terminategongoinggstudiesgwhengitgwouldgnotgendangergsubjects.
4. Notifygstate/federalgagenciesgwhengappropriate.gParentginstitutiongis
gresponsiblegforgIRB
, P a g e g |g4
ThegIRBgwillgdeterminegifgagstudygisgmorallygjustifiedgandgdemonstratesgwhatg
keyg4gitems?g-gcorrectganswerg-g1.gAdequategdesign
2. agfavorablegrisk/benefitgratio
3. equitablegselectiongofgsubjects
4. informedgconsentgbygsubjects
Whatgallgdoesgtheg1572gcontain?g-gcorrectganswerg-
g1.gName/Addressgofginvestigator
2. Namegandgprotocolg#
3. Namegandgaddressgofgeverygfacilitygwheregclinicalginvestigationsgwillgtake
gplace
4. Name/Addressgofganygclinicalglab
5. Name/AddressgofgIRB
6. Agcommitmentgbygtheginvestigator
CommongDeficienceisgofgFDAginspectionsg-gcorrectganswerg-
gFailuregtogfollowgprotocol,gDeviations,gInadequategrecordgkeeping,gInadeq
uategaccountability,gICFgissues/subjectgprotections
OHRPg-gcorrectganswerg-gOfficegForgHumangResearchgProtections.
1. ProtectsgvolunteersgingresearchgconductedgsupportedgbygUSgDept.gof
gHealthgandgHumangServices
2. UsuallyginspectsgIRBs
SOCRA CERTIFICATION 2025 ACTUAL EXAM Q
g g g g g
UESTIONS WITH 100% CORRECT SOLUTIONS
g g g g
| GUARANTEED SUCCESS.
g g
Usegofgplacebog-gcorrectganswerg-
gThegbenefits,grisks,geffectivess,getc.gmustgbegtestedgexcept:gWhengnogprov
engintervetiongexists.gThengthegusegofgplacebo,gorgnogintervetiongisgaccepta
ble.gAlso,gifgagcompellinggandgscientificgmethodologicalgreasonsgforginterven
tion
PublicgDiscolsuregwithgINDsg-gcorrectganswerg-
g1.gINDgwillgnotgbegdisclosedgunlessgpreviouslygdone.
2.gFDAgwillgdisclosegupongrequestgtogangindividualggivengangINDghasgbeengg
ivengcopygofgreportgonghowgitgrelatesgtoguse.
ReportinggTimegFramesg-gcorrectganswerg-
g1.gFatalgorgLifegthreateninggunexpectedgADRsg-
gQualifygforgrapidgreportingg-gASAPg-gnoglatergthang7gdaysg-
gfollowgupgreportgnoglatergthang8gadditionalgdays.
2.gAllgothergserious,gunexpectedgADRsgmustgbegfiledgasapg-
gbutgnoglatergthang15gcalendargdays.
IRBgwillgdeterminegifgstudygisgmorallygjustifiedgandgdemonstratesgwhatg4gkey
gitems?g-gcorrectganswerg-g1.gAdequategDesign.
2. FavorablegRisk/Benefitgratio.
3. Equablegselectiongofgsubjects.
4. ICFgofgsubjects.
, P a g e g |g2
AdversegEventg(Definition)g-gcorrectganswerg-
gAnyguntowardgmedicalgoccurrencegassociatedgwithgthegusegofgagdrugginghu
mansgwhethergorgnotgconsideredgdruggrelated.gItgcangthereforegbeganygunfa
vorablegandgunintendedgsign,gsymptom,gorgdiagnosisgassociatedgwithgthegu
segofgagmedicinalginvestigationalgproductgwhethergorgnotgrelated.
Explaingthegrulesgrelatinggtogfinancialgdisclosure?g-gcorrectganswerg-
gResponsiblegforginmplementinggthegpublicgandgconfidentialgfinancialgdisclu
sregsystemsgtogpreventgconflictsgofginterestgandgtogidentifygpotentialgconflicts
gbygprovidinggreviewgofgthegfinancialginterestgingbothgcurrentgandgprospectiv
egemployees.
Whatgisgminimalgrisk.g-gcorrectganswerg-
gThegprobabilitygandgmagnitudegofgharmgorgdiscomfortganticipatedgingthegres
earchgaregnotggreatergingandgofgthemselvesgthangthosegordinarilygencounter
edgingdailyglife.
AssentgforgChildreng-gcorrectganswerg-
g1.gPermissiongofgeachgchild'sgparentsgmustgbeggranted.gMightgbegonegorgbot
h.gMustgbegdocumented.
2. Assentgshouldgbegobtainedgunless.gCapacitygofgchildgisglimitedgsogthey
gcan'tgunderstand.gInterventiongofgtrialgisgbeneficialgandgonlygavailablegth
roughgtrial.
3. OrgifgIRBgfeels:gNogmoregthangminimalgrisk.gWaivergwillgnotgaffectgsubject
grights.gResearchgcouldn'tghappengwithoutgassent.gAdditionalginfogprovided
gasgneeded.
, P a g e g |g3
WhatgciricalgquestiongmustgbegansweredgbygthegIRB?g-gcorrectganswerg-
gDoesgthegsumgofgbenefitsgandgimportancegofgknowledgeggainedgfromgrese
archgoutweighgrisksgtogpartipants?
WhengisgitgokgtogtestgagnewginterventiongagainstgagPlacebogandgnotgagainstg
bestgprovengintervention?g(DeclarationgofgHelsinki)g-gcorrectganswerg-g1.
Whengnogprovenginterventiongexists.
2. Soundgmethodicalgreasonsgrequiresgitgtogdeterminegefficacygorgsafetygof
gangintervention.
3. Subjectsgthatgreceivegplacebogwillgnotgbegsubjectgtogadditionalgrisksgduegto
gnotgreceivinggbestgoption
HowglonggaregIRBgregistrationsgeffective?g-gcorrectganswerg-g3gyears
AdministrativegActionsgforgNon-CompliancegforgIRBsg-gcorrectganswerg-
gIfgFDAgobservesgnon-compliancegduringginspection:gMay
1. withholdgapprovalgofgnewgstudies.
2. Nognewgsubjectsgbegaddedgtogongoinggstudies.
3. Terminategongoinggstudiesgwhengitgwouldgnotgendangergsubjects.
4. Notifygstate/federalgagenciesgwhengappropriate.gParentginstitutiongis
gresponsiblegforgIRB
, P a g e g |g4
ThegIRBgwillgdeterminegifgagstudygisgmorallygjustifiedgandgdemonstratesgwhatg
keyg4gitems?g-gcorrectganswerg-g1.gAdequategdesign
2. agfavorablegrisk/benefitgratio
3. equitablegselectiongofgsubjects
4. informedgconsentgbygsubjects
Whatgallgdoesgtheg1572gcontain?g-gcorrectganswerg-
g1.gName/Addressgofginvestigator
2. Namegandgprotocolg#
3. Namegandgaddressgofgeverygfacilitygwheregclinicalginvestigationsgwillgtake
gplace
4. Name/Addressgofganygclinicalglab
5. Name/AddressgofgIRB
6. Agcommitmentgbygtheginvestigator
CommongDeficienceisgofgFDAginspectionsg-gcorrectganswerg-
gFailuregtogfollowgprotocol,gDeviations,gInadequategrecordgkeeping,gInadeq
uategaccountability,gICFgissues/subjectgprotections
OHRPg-gcorrectganswerg-gOfficegForgHumangResearchgProtections.
1. ProtectsgvolunteersgingresearchgconductedgsupportedgbygUSgDept.gof
gHealthgandgHumangServices
2. UsuallyginspectsgIRBs
